IMRT treatment planning via biological objectives gives rise to constrained nonlinear optimization problems. We consider formulations with nonlinear objectives based on the equivalent uniform dose (EUD), with bound constraints on the beamlet weights, and describe fast, flexible variants of the twometric gradient-projection approach for solving them efficiently and in a mathematically sound manner. We conclude that an approach that calculates the Newton component of the step iteratively, by means of the conjugate-gradient algorithm and an implicit representation of the Hessian matrix, is most effective. We also present an efficient heuristic for obtaining an approximate solution with a smoother distribution of beamlet weights. The effectiveness of the methods is verified by testing on a medium-scale clinical case.
Introduction
The use of optimization and operations research techniques in cancer treatment planning with intensity-modulated radiation therapy (IMRT) has been the subject of much recent research; see Zhang et al (2004) , Romeijn et al (2004) , Alber and Reemtsen (2005) , Thieke et al (2003) and Stavrev et al (2003) for just a few examples of recent work. Many mathematical formulations have been proposed, all of which attempt to capture the multiple goals of delivering a prescribed dose of radiation to the tumour while avoiding excessive dose to surrounding tissue, particularly to critical structures that lie near the tumour.
We can distinguish two different approaches to the mathematical formulation of the problem. The first approach uses 'physical' objectives, in which the dose delivered to each region in the patient's body is compared directly to a dose distribution prescribed by the physician. An objective function is calculated from the difference between the actual and desired doses; see Llacer et al (2003) , Hou et al (2003) and Zhang et al (2004) . The objective functions in these formulations are usually linear or quadratic functions of the beamlet weights, and some or all of the constraints are linear; see, for example, Rosen et al (1991) , Shepard et al (1999) , Lim (2002) , Wu (2002) and Romeijn et al (2003) . Often, these formulations also include dose-volume (DV) constraints, which typically require that no more than a specified fraction of volume of a given region receives a dose of higher than a certain specified level. These constraints are more difficult to formulate; a number of techniques have been proposed to handle them, including integer programming (Lee et al 2003) , nonlinear programming (Shepard et al 1999) , and solution of a sequence of weighted linear programs (Shepard 2001) .
A second approach to formulation of the treatment planning problem calculates nonlinear functions of the dose distribution that attempt to measure its biological efficacy; see, for example, Zhang et al (2004) , Wu et al (2002) and Alber and Nüsslin (1999) . These functions might measure the probability of tumour control (TCP) or the probability of complication arising from dose to the normal tissue (NTCP). Hybrid formulations involving both physical and biological functions have also been studied; see, for example, Alber and Reemtsen (2005) , Thieke et al (2003) and Stavrev et al (2003) .
In this paper, we focus on a biological function known as the equivalent uniform dose (EUD), a concept introduced in Niemierko (1997) . Previous work involving EUD-based objectives has been carried out by Wu et al (2002 Wu et al ( , 2003 and Zhang et al (2004) . Use of EUD in the context of an optimization model was first described in Niemierko (1997) , where it was suggested to maximize EUD for the target subject to dose and dose-volume constraints on the normal tissue. In Wu et al (2002) , a formulation involving EUD combined with a sigmoidal logistic function was optimized using gradient descent algorithms. This work was continued in Wu et al (2003) , where the authors came to the conclusion that fine-tuning of DV plots is too difficult using EUD alone. They devised a hybrid optimization scheme that successively minimized different optimization formulations involving DV constraints and biological and physical objectives. Different algorithms were compared in Zhang et al (2004) for both physical objectives and the EUD-based objective from Wu et al (2002) . A method in which the gradient was scaled by a diagonal approximation to the Hessian proved to be the most effective. (Our 'diagonal approximation' variant is inspired by this approach, but differs in its handling of the nonnegativity constraints and in step selection.)
Given a certain (nonuniform) dose distribution over a region, the EUD is the dose which, when distributed uniformly across the region, has the same effect in terms of eliminating clonogens as the given dose distribution. By penalizing the differences between the EUD and the prescribed doses to each region (tumour, critical structures, normal tissue), we construct a nonlinear objective, which we then minimize subject to bound constraints on the beamlet weights. Our goal is to devise fast, flexible optimization schemes for solving such problems. We describe several variants of a two-metric gradient-projection algorithm for bound-constrained optimization, in which different techniques are used to define and calculate the Newton component of each step. These variants are as follows.
(i) A diagonal variant that uses a diagonal approximation to the Hessian to calculate the Newton component of the step, similarly to Zhang et al (2004) . (ii) A finite-difference variant that uses a conjugate-gradient approach to calculate the Newton component, and uses finite differencing of gradient values to approximate the Hessianvector products required by the conjugate gradient. (iii) An explicit Hessian variant that calculates the Hessian submatrix corresponding to the Newton component of the step explicitly, using it to form exact Hessian-vector products in the conjugate-gradient step calculation procedure.
(iv) An implicit Hessian variant similar to (iii), but storing Hessian information in a compact, implicit format made possible by the special properties of the EUD objective.
We find that variant (iv) generally yields a good solution at minimum computational cost. We also describe an efficient heuristic, based on our two-metric gradient-projection algorithm, for finding 'smoothed' approximate solutions in which the beamlet weights are distributed more uniformly than in the true solution. Such solutions are desirable for a number of reasons, including lower beam-on time required for delivery, fewer apertures required by the leaf-sequencing procedure, and reduced sensitivity to patient and organ movement.
Our algorithms assume that the various EUD-based objectives for each region in the treatment area are combined into a single nonlinear objective by using logistic-function transformations and weighting parameters. We can obtain solutions for different sets of weighting parameters by using the optimal beamlet weights for one set of weights as an initial point ('warm start') for a nearby set of weights. In this way, we can efficiently build up an 'efficient frontier' for a multiobjective formulation of our treatment planning problem. Other authors , Romeijn et al 2004 use an explicit multiobjective viewpoint in conjunction with approximations to the EUD and convexified objectives.
We used a stopping criterion for our algorithms that is insensitive to poor scaling in the problem and that causes the algorithm to terminate in the neighbourhood of a local solution. We found, however, that our criterion sometimes causes termination too far from the solution. More work is needed to spell out desirable properties for termination criteria and to design criteria with these properties.
The remainder of the paper is structured as follows. Section 2 contains background on IMRT and on EUD functions, together with a discussion of the problem formulation. Our algorithms are described in section 3. We describe our data set and present our computational results in section 4. Section 5 discusses our conclusions.
Mathematical formulations
In this section, we give background on treatment planning, biological objectives and optimization formulations. Notation is defined in section 2.1, while the EUD function is described in section 2.2. Section 2.3 is a description of the optimization formulation used in this paper. In appendix A of the appendix we specify the derivatives of the EUD-based objective functions, showing the structure that can be exploited in implementing our algorithms.
IMRT: Background and notation
For planning purposes, the treatment region in the patient's body is divided into box-shaped regions known as voxels, indexed as i = 1, 2, . . . , m. Each of the apertures through which radiation can be delivered into the patient's body from various angles is divided into rectangular beamlets, which we index as j = 1, 2, . . . , n. The dose of radiation delivered to voxel i by a unit weight (intensity) in beamlet j is denoted by A ij ; these quantities can be assembled into a dose matrix A of dimension m × n. Since doses scale linearly with weight and are additive across beamlets, we can express the total dose D i to voxel i from beamlet weights w 1 , w 2 , . . . , w n as follows:
We write this equation more concisely using matrix and vector notation as follows:
In most approaches to IMRT treatment planning, the beamlet weights are the (nonnegative) variables in the optimization formulation. The objective functions and constraints are constructed mostly from the doses D i , i = 1, 2, . . . , m, though there may also be some constraints that are explicit functions of the weights. The size of the planning problem depends on the number of beamlets and voxels, and varies significantly from case to case. Clinical data sets used in the computational experiments of Hou et al (2003) , Llacer et al (2003) , Alber and Reemtsen (2005) and Zhang et al (2004) typically involve 1000-5000 beamlets and up to 100 000 voxels.
The dose matrix must be calculated for each patient. There are inaccuracies and uncertainties in the dose matrix entries, because of model and simulation error, patient movement during treatment, and movement and shrinkage of the organs during the treatment (which usually stretches over a 4-8 week period). Consequently, treatment planning algorithms need not be iterated to a highly accurate solution; fairly loose stopping criteria are adequate for practical purposes.
In treatment planning, the set of voxels {1, 2, . . . , m} is partitioned into one or more target volumes T (containing the tumour and possibly surrounding tissue), one or more critical structures C, and a region of normal tissue N . Generally, a dosimetrist tries to devise a plan in which the target voxels receive dose close to a specified value (prescribed by a physician), while dose to the critical and normal regions is avoided. Critical regions are distinguished from other normal tissue because they involve organs or structures that, when irradiated, can have a serious effect on the patient's quality of life. Some dosing of the regions C and N is usually unavoidable, because they are adjacent to the target or because the radiation must travel through them to reach the target. The physician may specify penalties and constraints of varying types to discourage excessive dosage to the regions C and N .
Equivalent uniform dose (EUD)
Mathematically, the EUD on a region R is defined as follows,
where a is a tissue-specific parameter that may be positive or negative. The EUD was defined originally in Niemierko (1997) for the case in which R is a tumour. In Niemierko (1999) , the EUD concept was extended to non-tumour regions. Both negative and positive values of a are useful in constructing objective functions and constraints based on EUD. For a = 1, the EUD measures the average dose to the voxels in the region R, while for a → ∞, EUD approaches the maximum dose taken over all the voxels in R. For negative values of a, the EUD is defined only when D i > 0 for all i ∈ R. As a → −∞, EUD becomes proportional to the minimum dose min i∈R D i . EUD functions can be used to define 'soft' upper and lower bounds on the dose to the region R. For example, we can discourage doses of less than a certain level to the voxels in the region R by choosing a < 0 in (2) and enforcing the constraint EUD(w; R, a) EUD 0 , or by including a term in the objective function that is small when EUD EUD 0 but which grows rapidly as EUD drops below EUD 0 . We discuss this point further in the next subsection. For more details on how to choose values of a, see Wu et al (2002) . 
Combining EUD with a logistic function
The optimization model used in this paper is based on the following two logistic functions of EUD,
where ν > 0 is a user-defined parameter that indicates the importance of each structure and EUD 0 is a parameter representing the maximum or minimum desired EUD for the voxels in region R. The notation L is used for (3b) as it is useful in formulating constraints of lowerbound type, for the target volumes. Figure 1 (a) shows a plot of −ln L as a function of EUD, for different values of the parameter ν and for EUD 0 = 65. Note that for EUD EUD 0 , the function value is close to zero, while it increases as EUD drops below EUD 0 . (Larger values of ν cause a more rapid increase.) The function is convex with respect to EUD. The function U in (3a) is used to represent upper-bound type constraints. The plot in figure 1(b) shows −ln U as a function of EUD for different values of ν and for EUD 0 = 5. The plot shows that the function value is small for EUD EUD 0 and grows as EUD increases above EUD 0 , again with more rapid growth for larger ν. This function becomes nonconvex in the region EUD > EUD 0 , though for values of EUD below or slightly greater than EUD 0 (a region in which the solution can be expected to lie, if the problem is posed appropriately), it appears to be convex. As in Wu et al (2002) and Zhang et al (2004) , we define the objective function to be a sum of functions −ln L(w; R, a, ν, EUD 0 ) and −ln U(w; R, a, ν, EUD 0 ) for various regions R, and for various values of a and ν. For example, in a simple problem with a single target region T and a normal region N , the objective function could be
where a T < 0 and a N > 0. The first term tends to enforce a lower bound on the dose to the target voxels, while the second term tends to enforce an upper bound on the dose to the normal voxels. The choices of ν T and ν N define the relative importance of satisfying these bounds, while EUD 0,T and EUD 0,N can also be 'tuned' so that the optimization yields a dose distribution with properties that the planner deems to be desirable. The examples discussed in section 4 have more elaborate objectives based on multiple critical regions, and on the use of both maximum and minimum target values for EUDs on the target region.
Optimization techniques
EUD-based treatment planning problems formulated as in (4) are bound-constrained nonlinear optimization problems with a large number of variables (the beamlet weights). The two-metric gradient projection Bertsekas (1982) has proved to be effective on problems of this type. Efficiency of this approach is enhanced greatly by the use of second derivative information in the reduced Newton step, which is calculated in the subspace of variables that do not appear to be at their bounds. As observed by Alber et al (2002) , however, the Hessian of the EUD-based objective is typically quite dense, with a spectrum consisting of a few distinct large eigenvalues and many smaller eigenvalues. We are motivated, therefore, to consider methods that do not require storage or factorization of the full Hessian, and that can take advantage of the nature of its spectrum. Accordingly, in three of our algorithmic variants, we use the conjugate-gradient approach to calculate the reduced Newton step. The conjugate-gradient algorithm requires one matrix-vector multiplication involving the reduced Hessian at each iteration. One of our variants (finite-difference) approximates this Hessianvector product using first-derivative information, thereby avoiding the calculation of second derivative altogether. Another variant (explicit Hessian) computes and stores the reduced Hessian matrix at each iterate. A third variant (implicit Hessian) stores the reduced Hessian in a compact, implicit form that nevertheless allows efficient calculation of Hessian-vector products. The fourth variant is similar to the 'Newton' approach described in Zhang et al (2004) , in which the Hessian is approximated by its diagonal elements. We note that all these methods are modified to take account of the fact that the reduced Hessian may be indefinite when the current iterate is not close to the solution. Early termination of the conjugate-gradient procedure upon detection of indefiniteness ensures that the search direction still yields a valid step for the two-metric algorithm. We describe the two-metric gradient-projection framework in section 3.1. Sections 3.2 and 3.3 describe our different variants for calculating the Newton-like component of the search direction. Finally, in section 3.4, we discuss a heuristic for finding a smooth approximate solution, in which all variables are bounded above by a specified multiple of the average of the nonzero components. This heuristic is used to find a smoothed solution of the IMRT treatment planning problem.
We make use of the following notation. Given a vector v with n elements, and an m × n matrix B, and index sets I ⊂ {1, 2, . . . , m} and J ⊂ {1, 2, . . . , n}, we define v J to be the subvector consisting of the elements v j for j ∈ J , and B IJ to be the submatrix consisting of the elements B ij for all i ∈ I and j ∈ J . We denote by B I· the row submatrix of B corresponding to the rows i ∈ I, and B ·J the column submatrix of B corresponding to the columns j ∈ J .
Two-metric gradient projection
Gradient projection allows significant changes to the active set (the set of indices that appear to be at their bounds) at each iteration, and often identifies the optimal active set in relatively few iterations. The basic method obtains each new iterate by searching along the negative-gradient direction, projecting onto the feasible set and using a backtracking strategy which repeatedly reduces an unsuccessful step length by a constant factor until it yields a sufficient decrease in the objective. The two-metric gradient-projection algorithm, described in Bertsekas (1982) , Gafni and Bertsekas (1984) and Kelley (1999) , replaces the negative-gradient direction in the subspace of inactive components by a Newton-like step on these components. This approach can exhibit rapid local convergence once the correct active set has been identified, since it reduces to a Newton-like method on the subspace of inactive components.
We describe the two-metric approach briefly in terms of the following problem with nonnegative variables,
where f : R n → R is a smooth nonlinear function. A point w * is stationary for (5) 
Second-order sufficient conditions for w * to be a local solution of (5) 
2 for all v in the following direction set:
When strict complementarity holds (that is, ∇f (w * ) i > 0 for all i ∈ A * ), the second-order sufficient condition reduces to positive definiteness of the Hessian submatrix ∇ 2 f (w * ) I * I * . Given an iterate w k , we consider points of the form w k (α) for the next iteration, where
where the search direction s k is defined as the solution of the following linear system,
where G k ∈ R n×n is a symmetric positive definite matrix. To construct G k , we start by defining the approximate active set A k as follows,
where k is defined as
and > 0 is a small positive parameter (typically 5 × 10 −4 ). It is easy to show that k = 0 if and only if w k is stationary. Supposing without loss of generality that
whereḠ k is symmetric positive definite (of size r k × r k ) and g k i > 0, i = r k + 1, r k + 2, . . . , n. With this choice of G k , the search direction s k from (7) is partitioned into a scaled steepest descent direction (in the A k components) and a Newton-like step (in the I k components). Positive definiteness ofḠ k ensures that
where the inequality is strict unless ∇f (w k ) I k = 0. If we setḠ k = I and g k i = 1 for all i, we recover the standard gradient-projection method.
We discuss different choices ofḠ k and (possibly inexact) solution of (7) in the subsections below, but make a few more comments here about the choice of diagonal scaling factors g k i , i ∈ A k . To make these values commensurate with the general size of elements of the Hessian ∇ 2 f (w k ), we set
Note that this choice requires knowledge of all diagonals of ∇ 2 f (w k ), but for the EUDbased objective, the expense of evaluating the diagonals is significantly less than the cost of evaluating a full Hessian.
To generate the new iterate w k+1 , we try values
for the step length parameter α in succession, where β ∈ (0, 1) is a user-selected parameter (typically β = 0.5) and γ k represents our initial guess for the step length. The step length α k is chosen to be the first value of α in this sequence that satisfies the acceptance criterion (14) below. Following Bertsekas (1982) , the value α is accepted as the step length parameter provided it satisfies the following criterion,
where σ is a small positive parameter (we use σ = 0.1). With α k in hand, we set w k+1 = w k (α k ). A specification of the complete algorithm appears as Algorithm 1 , which we also refer to as Algorithm 2MGP in subsequent discussions.
Choose convergence tolerance > 0 and active-set tolerance ; Choose line-search parameters β ∈ (0, 1) and σ ∈ (0, 1);
Choose starting point w 0 ;
Stop with approximate solution w k ;
end Calculate A k and I k from (8);
Find the search direction s k from (7) (or an approximation), using one of the procedures from subsections 3.2 and 3.3;
Perform the backtracking linesearch (13) to find α k satisfying (14); if α k < 10 −4 then Stop (error termination); end
end Algorithm 1: Algorithm 2MGP: two-metric gradient projection.
A typical value of the termination parameter is = 0.005. Note that the algorithm has two stopping criteria, the first one based on an optimality measure and the second one yielding an error termination when the step size becomes very small.
Convergence of this approach has been described by Bertsekas (1982) . He shows in Bertsekas (1982, proposition 2) that if ∇f is Lipschitz continuous on each bounded subset of R n , and when G k in (7) satisfies reasonable assumptions, every accumulation point of the sequence generated by Algorithm 2MGP is a stationary point. In Bertsekas (1982, proposition 3), he shows that when strict complementarity and second-order sufficient conditions hold at some solution x * , then if the sequence of iterates passes sufficiently close to x * , it converges to x * and we have A k = A * for all k sufficiently large. Moreover, under further assumptions on G k , the rate of convergence is superlinear Bertsekas (1982, proposition 4) . These results would need to be extended and adapted slightly in order to apply to some of our approaches, which allow s k to be calculated approximately using iterative approaches, but we believe that such extensions would be straightforward.
Computing the search direction: direct approaches
We now focus on the choice ofḠ k for calculating the search direction s k from (7) and (10). In this section, we discuss techniques that use direct (rather than iterative) linear algebra techniques.
As mentioned above, the simple choiceḠ
. . , n yields the standard gradient-projection algorithm, which reduces to the steepest descent algorithm when the constraints w 0 are not present. We cannot expect rapid convergence or even robustness, as the convergence rate may be exceedingly slow. We did not implement this variant.
A second possibility is an exact reduced Newton step, in which we setḠ k to the reduced Hessian; that is,Ḡ
so that (7) becomes
We could solve this system via a Cholesky factorization of the reduced Hessian, followed by two triangular substitutions. When the reduced Hessian is found not to be positive definite, we can add a nonnegative multiple of the identity matrix, and obtain the step instead from
for some ρ k > 0.
As noted by Alber et al (2002) and Zhang et al (2004) , full Hessians (A.4) are expensive to evaluate for our particular problem. However, this approach is not out of the question when the reduced Hessian is much smaller than the full Hessian, that is, when |I k | n. We did not implement this variant, however, since factorization of the reduced Hessian is usually more expensive than approximate solution of (7) via conjugate gradients, which forms the basis of the 'explicit Hessian' variant described below.
A third approach is to use just the diagonal elements of the reduced Hessian, modified appropriately to ensure positivity. We set
where χ k is some positive parameter. We could choose χ k in a similar way to g k i , i ∈ A k in (12), to ensure that the diagonal elements ofḠ k are all commensurate with the diagonals of the true Hessian matrix. A diagonalized Hessian was also used in Zhang et al (2004) but not in the context of a true projected gradient approach.
We report results for the last variant, which we refer to as the 'diagonal approximation', in section 4.
Choosing the search direction: iterative approaches
Consider now the use of iterative schemes for solving (16) approximately. We ensure that the essential property (11) holds for the computed step s k I k . The main computational requirement for iterative approaches is the ability to calculate (approximate) matrix-vector products involving the reduced Hessian [∇ 2 f (w k )] I k I k . The conjugate-gradient method forms the basis of our iterative schemes. It was observed by Alber et al (2002) that the Hessian ∇ 2 f (w k ) of a function f of the type discussed in section 2.3 typically has only a few large eigenvalues, with the remainder clustered near zero. The same properties hold for the reduced Hessian in (16). It is well known that for systems of the form H z = b, where H is positive definite with a few large eigenvalues and b lies mostly in the eigenvector subspace corresponding to the large eigenvalues, the conjugate-gradient method finds a good approximate solution in just a few iterations-at most as many iterations as there are large eigenvalues. (This claim is a consequence of Conn et al (2000) (5.1.36) for example.) An informal analysis in appendix B shows that we can expect these conditions to hold in the case of (16), for w k near w * . The conjugate-gradient approach needs to be modified slightly to calculate an approximation to the reduced Newton step, since the coefficient matrix in (16) may not be positive definite except near the solution. The description of our procedure is shown as Algorithm 2 (which we refer to also as Algorithm mCG). Since our implementation differs slightly from the description in Nocedal and Wright (1999) , we give details here.
In our experiments we set the parameters maxCGiter and CGtol to 40 and 0.15, respectively.
The main difference between standard conjugate gradient and Algorithm mCG is the test for negative curvature in H. Regardless of how the algorithm terminates, the final step y j satisfies y T j b 0. The main operation at each iteration is calculation of the matrixvector product Hp j , where H is the coefficient matrix in (16). Schemes for calculating or approximating this product are described in sections 3.3.1 and 3.3.2. 
Finite-difference approximation. Here we consider approximating the matrix-vector product
by a finite-difference approximation. When this approach is used, it is not necessary to calculate any part of the Hessian expressions in (A.2). Assuming as in (10) that the I k components appear first, we can write the current iterate w k as
The vector p in the product (19) is expanded to a full-length vectorp by adding zero components in the A k positions; that is,
The finite-difference approximation is then
for a small scalar value of h. (In experiments we used h = 10 −8 .) Because f (w) is defined only when x 0, we need to modify the usual finite-difference formula, since the vector w k + hp may have some slightly negative components. We split p into two vectors p 1 and p 2 with the following properties:
Then by lettingp
We can then use the approximation
as the approximate matrix-vector product in Algorithm 2.
Implicit and explicit Hessian variants.
We can calculate the product (19) exactly (to within finite precision) in two ways. The first way is simply to calculate the reduced Hessian explicitly from the formulae (A.1a) and (A.2b). The second approach is to store enough information about this reduced Hessian to allow the product to be computed efficiently. For purposes of description we assume that the Hessian is defined by (A.4a). Incorporation of multiple terms of this form, and terms of the form (A.4b), can be performed with similar techniques. We define the coefficients in the two terms of (A.4a) as follows:
and set
The full Hessian is then
The reduced Hessian is obtained by considering only those columns of the dose matrix A from the set I = I k . This matrix is
In the explicit approach, H is calculated according to this formula and stored.
In the implicit approach, we write the product (19) as
and calculate the product according to the placement of parentheses. To this end, we store the vector d I and the diagonal matrix at the start, and at each iteration we perform a matrix-vector product involving the dose submatrix A RI and its transpose.
Enforcing uniformity of beamlet weights
While highly nonuniform plans often produce dose distributions that match the prescribed distributions closely (that is, satisfy the conformality requirement), they often require a high beam-on time, leading to higher potential leakage. In IMRT treatment planning, there is evidence that smoother treatment plans can be delivered using fewer apertures (Otto and Clark 2002, section 3.1.4) and are more 'robust', in that the consequences of errors in the delivered weights or of patient and organ movement are less severe than highly nonuniform plans; see Webb et al (1998) .
One way to impose smoothness on a treatment plan is to restrict the maximum beamlet weight to some modest multiple (say 3) of the average weights of the nonzero beamlets. Exact formulation of optimal plans of this type is difficult to achieve without the use of binary variables. However, good approximate solutions can be obtained by making use of Algorithm 2MGP, slightly modified to include an upper bound on each beamlet weight (in addition to the lower bound of zero). The upper bound can be adjusted in an 'outer loop' to ensure that the final solution restricts the maximum beamlet weight to approximately some specified multiple (ζ , say) of the average nonzero beamlet weight.
Given an upper bound u on each beamlet weight, three key modifications to Algorithm 2MGP are required. First, the definition of the approximate active set is changed from (8) to
while I k is {1, 2, . . . , n}\A k as before. Second, in the step length calculation and the definition of the new iterate, the nonnegativity operator [y] + is replaced by the projection P (y, 0, u) defined by
Finally, the stopping criterion involving is replaced by
The framework for obtaining the smoothed solution is shown below as Algorithm 3, which we also refer to as the Smoothing Algorithm. Typical values for the parameters arẽ = 0.005, ζ = 3, and ψ = 0.1.
Computational results
We tested our variants of Algorithm 2MGP extensively on two clinical data sets. The first case, a nasopharyngeal tumour, was medium in scale, with about 24 000 voxels. The second case, a prostate cancer case, involved about 2 million voxels. In the interests of space, we report on results only with the smaller data set, and summarize the results obtained on the larger data set in the final section.
Define the desired multiple ζ > 1 and tolerance ψ ∈ (0, 1);
Run Algorithm 2MGP (with no upper bound) to obtain solution w 0 ;
Let u = w 0 ∞ ;
Define µ 0 to be the average nonzero value of w 0 ;
Set j = 0;
Run Algorithm 2MGP (modified for an upper bound) from starting P (w j , 0, u) to obtain solution w j +1 ;
Define µ j +1 to be the average nonzero value of w j +1 ; j ← j + 1; end Algorithm 3. Smoothing Algorithm for enforcing uniformity of beamlet weights.
We start by describing the properties of the nasopharyngeal data set, then discuss the four variants of Algorithm 2MGP that were tested in this study. We present results for these variants, discussing both the quality of the solutions obtained and the computational efficiency. We also discuss results obtained with the Smoothing Algorithm.
The nasopharyngeal tumour data set was also used by Wu (2002) . This is a twodimensional problem; treatment is carried out in a single axial plane through the patient. The 24 000 voxels are divided into five regions: tumour and 'region' of the tumour (which together constitute the target); parotids and spinal cord (the critical structures); and the normal region. There are a total of 1989 beamlets, consisting of 39 beamlets from each of 51 angles.
Experimental set-up
We describe results obtained using four variants of Algorithm 2MGP. The variants differ in the calculation of the I k components of the search direction: we use the diagonal approximation of the reduced Hessian (see (18) in section 3.2) and the three iterative methods described in section 3.3. We also discuss results for the Smoothing Algorithm.
All algorithms were coded in Matlab 7.0.4. Experiments were performed on a computer with a 1.8 GHz Intel(R) XEON(TM) processor running Tao Linux 1.0. Cache size was 512 MB and total memory was 8 GB.
Default settings of parameters for the algorithms of section 3 are CGtol = 0.15, maxCGiter = 40, = 0.0005, β = 0.5, σ = 0.1, ζ = 3, and ψ = 0.1. The values of σ and β are standard in optimization context of using the backtracking line search, while the small choice of is suggested by Bertsekas (1982) . The values of CGtol and maxCGiter seemed reasonable in the context of large-scale optimization, while the choice of smoothing parameter ζ and tolerance ψ seemed reasonable from a clinical viewpoint. From our experience, the parameter to which the results are most sensitive is the convergence tolerance ; we tried various values of this parameter, as reported below. The initial vector of weights w 0 is random, with components uniformly distributed in the interval [0, 10] .
It is common to use DVH curves to evaluate the quality of a radiotherapy treatment plan. It is arguable, however, that this metric is appropriate for treatment plans based on EUD functions, which are motivated by biological considerations rather than from a desire to match a given dose distribution in a physical sense. We share the concerns raised in Wu et al (2003 p 282) that 'when DVH is used for prescription and plan evaluation' the main weakness of EUD-based modelling is the difficulty of fine-tuning the DVH plot. Wu et al (2002) argue that only the weighting parameters ν for each term in the EUD objective should be varied during the process of refining the treatment plan, since the other parameters in the model are well defined either by the intrinsic biological properties of the organ (in the case of the parameter a) or by the prescription (in the case of the parameter EUD 0 ). Our results presented below are of two basic types. In the first type (the 'biological perspective') we varied only the weighting parameters ν, fixing a at values obtained from the literature. In the second type (the 'DVH-motivated perspective') we varied all parameters EUD 0 , a and ν in an attempt to obtain a desirable DVH plot for the treatment plan.
We note that other authors have proposed combining EUD and physical terms in the same objective function; see Wu et al (2003) . We do not pursue this approach further here, but note that the algorithms of this paper could be applied to these formulations as well.
Results
In sections 4.2.1 and 4.2.2 we show results for different settings of the parameters EUD 0 , a and ν for the nasopharyngeal data set. In section 4.2.3, the Smoothing Algorithm is used along with the best variant from section 4.2.1 to find an approximate solution with a more uniform weight distribution. Table 1 shows the settings of the parameters EUD 0 , a and ν used to define the partial objectives (3) for each of the regions. The first two columns show the regions, while the third column indicates whether the function U from (3a) or the function L from (3b) is used. For the target regions, where we wish to constrain the dose to a certain range to avoid both underdosing and hot spots, contributions from both L and U appear in the objective. The values of EUD 0 , shown in the fourth column, were chosen according to the treatment plan that was presented with the data set. The fifth column shows the settings for the parameter a for each region. These values are obtained from Wu et al (2002) , where a nasopharyngeal case involving the same organs was described. For purposes of defining the functions U for the target regions, we use the normal-tissue setting a = 4.6, as in Wu et al (2002) . Our choices for ν are shown in the sixth column in table 1. We tried many possible settings for these parameters, but report on just one combination in this section. Table 2 shows the computational results for the four variants of our gradient-projection approach, using the settings in table 1 and the = 0.0005. Final objective values are shown in the second column. The slight difference in these final values could be due to either termination tolerance, convergence to different local minima (which is possible since the problem is nonconvex), or both. Examination of the final set of weights indicates that the first three cases may be converging to the same final solution, but the fourth case (which uses the diagonal approximation) may be heading for a slightly different solution, albeit one with the same main features as the other three cases.
Biological perspective.
The time to solve the model, as reported by the Matlab command cputime, is shown in column three. The number of iterations of Algorithm 2MGP is reported in the fourth column, while the number of iterations of Algorithm mCG, where applicable, is shown in the last column. Use of the exact Hessian (implicit and explicit) resulted in fewest outer iterations, and a modest number of inner iterations. Since the explicit and implicit Hessian approaches are identical (in exact arithmetic), it is not surprising that the iteration counts are the same for both. The implicit approach was considerably more efficient, however. Use of the diagonal approximation required more than twice as many outer iterations and a shorter overall run time. In the experiment reported in the last row of the table, we kept iterating the diagonal variant until it achieved an objective value of 4.405, similar to the optimum reported by the implicit Hessian variant. The run time was about an order of magnitude worse than the implicit Hessian variant, indicating slow local convergence. The most surprising result in table 2 was the poor performance of the finite-difference approach, for which the maximum number (40) of inner conjugate-gradient iterations were required on 74 of the 91 outer iterations. Closer examination of these results showed that approximately the first six outer iterations of the finite-difference approach mirrored those of the Hessian approaches, but that in subsequent iterations the true gradient was close to zero and the finite-difference approximation to it was inadequate. Consequently, the upper bound of 40 inner (mCG) iterations was reached repeatedly, while the computed search directions were poor and little progress was made towards the solution. When we used the more lenient stopping criterion = 0.005, as shown in table 3, the performance of finite difference was much closer to that of the exact Hessian methods, but the final objective value was about 10% higher in general than that obtained with the more stringent tolerance. The final EUD values for each region, obtained with the tighter termination tolerance = 0.0005 and the implicit Hessian variant, are shown in the last column of table 1. By comparing these values with the EUD 0 values from table 1, we note that the critical regions (spinal cord and parotids) both receive a lower EUD than the upper bound prescribed in the plan. The normal region and the target area receive slightly more than their EUD 0 values and the regional area receives less. Figure 2 shows the solution using a DVH plot and a physical representation of the dose distribution. We can see in figure 2(b) that the target is well covered, though a slightly lower maximum dose would be desirable. There are some weaknesses in the dose distribution to the regional area, where the lowest dose is only about 40 Gy. Whichever method is used to validate the solution, it is unlikely that good values for all parameters will be found in the first attempt. Therefore, it is important to have an algorithm that converges rapidly for each trial setting of the parameters. At least one of our variants (the implicit Hessian approach) meets this criterion, requiring less than a minute to converge to an accurate solution on this nontrivial problem.
DVH-motivated perspective.
In this experiment, we modified all of the parameters EUD 0 , a and ν in an attempt to obtain desirable DVH plots of the calculated treatment plan. We tried many combinations of values, following the guidelines given in Wu et al (2002) . We report on the parameter settings given in table 4 and show the results in figure 3 .
Comparison of figures 3 and 2 shows that the treatment plans are quite different for these different parameter settings. In figure 3 , the maximum dose for the target has been reduced to less than 75 Gy compared to more than 80 Gy previously, so the uniformity is better in this case. Since the regional area is receiving a higher minimum dose (an advantage) the neighbouring parotids also receive a higher dose (a disadvantage). However, the spinal cord is receiving much lower dose, which is another advantage. Table 5 shows the computational results for this case, obtained with a tolerance of = 0.01. The first three variants gave solutions not only with similar objective but also with similar beamlet weights whereas, as in the earlier experiment, the approximate solution given by the diagonal variant was somewhat different. As before, the best performance was obtained by the implicit Hessian approach. Unlike the previous data set, the implicit and explicit Hessian variants reported different numbers of outer and inner iterations, due to roundoff error effects which were magnified as the iterations progressed. The large number of outer iterations required by the diagonal Hessian approximation made this approach uncompetitive, while the iteration counts for the finite-difference approach were reasonable but the run time was slower by a factor of about 5 than the implicit Hessian approaches. In general, run times for this model were significantly greater than in table 2, due to the 'more nonlinear' nature of the objective resulting from the more extreme values of ν. The last column of table 4 shows the final EUD values obtained from the implicit Hessian variant. There is a greater variation from the EUD 0 in this case than in table 1. This is to be expected, however, since our aim in this experiment was to obtain a desirable DVH plot rather than to match the prescribed EUD values.
If the quality of a treatment plan is ultimately evaluated by means of a DVH plot (that is, by reference to the physical dose distribution), our experience indicates that use of biological objectives is not the most effective way to achieve an optimal plan. It is difficult to adjust the various parameters 'by hand' to achieve physical objectives that are in the mind of the treatment planner, rather than explicitly formulated and optimized. On the other hand, if the biological functions are trusted as giving an accurate reflection of treatment effectiveness, then it makes sense to optimize them directly and use the resulting plan.
Enforcing uniformity.
To apply the Smoothing Algorithm to these data, we used the parameter values ζ = 3 and ψ = 0.1, to ensure that the maximum beamlet weight was between 2.7 and 3.3 times the average nonzero beamlet weight. The convergence tolerance was set to˜ = 0.0005. We show results in table 6. The maximum weight of 566 units obtained in the iteration using only lower bounds is reduced to about 331 units in the iteration using both upper and lower bounds. Figure 4 shows the weights after each of the two iterations. Only one additional iteration of the Smoothing Algorithm (beyond the initial iteration which does not impose an upper bound) was required to smooth the solution. After the initial iteration, the maximum weight was 566, about 5.1 times the average nonzero value. For the next iteration, u was set to 330.5 and the final solution yielded an average nonzero weight of 105.4. About 34 beamlets reached the upper bound. Table 6 shows the computational results for each iteration of the Smoothing Algorithm, for the implicit Hessian variant. The total CPU solve time for this experiment was 39 s. Naturally, the results for iteration 0 are the same as those reported for the implicit Hessian method in table 2. The second iteration of the Smoothing Algorithm requires less time, because of the good starting point. Remarkably, the degradation in objective value due to the introduction of the upper bound constraint is minimal-about 1%. The DVH plot for these two iterations are shown in figure 5. The first iteration is shown as dashed lines while the second is shown as solid lines. We note very little difference between the two plans, except for a very slight increase in dose to the spinal cord for the smoothed solution.
Discussion and conclusions
We have shown that radiation treatment planning problems with EUD-based objectives can be solved efficiently using the two-metric gradient-projection approach. In particular, we found that a variant that computes the Newton part of each step iteratively using conjugate gradients, using an implicit representation of the Hessian, was most effective. We also introduced a simple and inexpensive heuristic that calculates a slightly suboptimal solution with a smoother distribution of beamlet weights.
As mentioned earlier, we also did extensive testing with a larger data set (a prostate cancer case) that involved over 2 million voxels and 3124 beamlets. The relative performance of the different variants of Algorithm 2MGP was similar to the reported nasopharyngeal case, though of course all run times were longer. (About 30 min of computation were required for the implicit Hessian variant, compared to 30-90 s for the smaller data set.) Solution quality was high, and the Smoothing Algorithm was just as efficient as for the smaller case.
Although our study has focused on EUD objectives, we believe that the algorithms can be extended to objectives that incorporate a combination of physical and biological terms. The gradient-projection approach cannot be extended easily, however, to problems that include constraints other than bound constraints on the weights. Such constraints can be handled by including penalty and augmented Lagrangian terms in the objective, as is done in Alber and Reemtsen (2005) In (A.4a), we have for a > 1 that the scalar multiplying the second term is positive. However, the scalar coefficient of the first (rank-1) term is negative when U(w; R, a, ν, EUD 0 ) < a/ν. When this inequality is satisfied, we have by the interlacing theorem (Golub and Van Loan 1989) that the Hessian may have a single negative eigenvalue, in which case −ln U loses convexity. For usual values of a and ν, this inequality is satisfied only when EUD(w; R, a) is significantly greater than EUD 0 ; that is, when the 'soft' upper bound is substantially violated. The most expensive aspect of evaluation of the functions L(w; R, a, ν, EUD 0 ) and U(w; R, a, ν, EUD 0 ) is calculation of the dose subvector D R , which requires a matrixvector multiplication A R· w. The quantities D i (raised to the power a − 1) can be reused in the gradient calculations (A.3), but an additional matrix-vector operation with A R· is needed. The results of the latter computation can be used in the Hessian calculation, in the evaluation of the first (rank-1) terms in each of (A.4a) and (A.4b). The second term in each of (A.4a) and (A.4b) is generally more expensive to evaluate, as it requires a matrix-matrix computation involving A R· and its transpose, together with the diagonal weighting matrix a−2 .
